Detection And Initial Response To A Type 2 Vaccine-Derived Poliovirus - Sichuan Province, China, 2019

Jiushun Zhou,Ning Wen,Yong Zhang,Qi Qi,Chunxiang Fan,Dongmei Yan,Xiaoping Zhu,Lixin Hao,Shuangli Zhu,Yu Liu,Xiaozhen Ma,Chao Ma,Lei Nan,Yong Chen,Qianli Ma,Cheng Wang,Kun Deng,Lei Cao,Ge Shao,Xianxiang Ding,Hong Yang,Zhijie An,Lance E Rodewald,Aiqiang Xu,Huaqing Wang,Zijian Feng,Zundong Yin,Xianping Wu,Wenbo Xu
DOI: https://doi.org/10.46234/ccdcw2020.045
2020-01-01
China CDC Weekly
Abstract:What is already known about this topic?After the type 2 strain of the live, attenuated poliovirus vaccine was withdrawn globally in 2016, any identification of a type 2 poliovirus is a Public Health Emergency of International Concern. A vaccine-derived type 2 poliovirus (VDPV2) was identified in Sichuan, prompting an urgent, comprehensive investigation and response.What is added by this report?Type 2 monovalent, live, attenuated oral poliovirus vaccine (mOPV2) is being used to respond to the numerous VDPV2 outbreaks seen around the world. In contrast, the response in Sichuan used Sabin strain inactivated poliovirus (sIPV) to stop circulation of the VDPV2. In the 6 months following the vaccination response, there have been no VDPV2s detected in Sichuan, despite extensive search.What are the implications for public health practices?Further search for the VDPV2 must continue in order to determine whether transmission has been stopped. The ongoing investigation and response to the Sichuan VDPV2 is providing evidence to the Global Polio Eradication Initiative on managing VDPV2 outbreaks.
What problem does this paper attempt to address?